CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD.CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD.CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD.

CHENGDU EASTON BIOPHARMACEUTICALS CO.,LTD.

No trades
See on Supercharts

688513 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and drug preparation. Its products include anti-tumor medicines such as Ubenimex capsules and ibandronate injections; cardiovascular medicines such as bisoprolol fumarate tablets; digestive medicines such as compound glycyrrhizin injections; anesthesia and analgesic products such as nalmefene hydrochloride injections and ibuprofen; and children’s medications. The company was founded by Ying Wang on June 1, 2009 and is headquartered in Chengdu, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688513 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company